SHARE

Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Porton Will Be Participating In Biotech Outsourcing Strategies Events This June
06.06.2024

Porton Will Be Participating In Biotech Outsourcing Strategies Events This June

Porton Will Be Participating In Biotech Outsourcing Strategies Events This June

As the global market for biopharmaceutical research outsourcing continues to flourish, the annual BOS Basel Conference has once again drawn worldwide attention. Since its inception in 2006, the Biotech Outsourcing Strategies (BOS) Events has become a barometer for the research outsourcing industry in Europe and globally. The organizers invite industry experts, business leaders, and scholars to explore key issues in biotech outsourcing, share successful experiences, and establish and strengthen collaborative relationships through a series of keynote speeches, specialized discussions, and roundtable forums.

BOS Basel 2024 is set to kick off in this June. This year's event will continue to focus on the outsourcing of CMC (Chemistry, Manufacturing, and Controls) for small molecules and biologics, with special attention to outsourcing developments in novel therapeutic areas (New Drug Modalities).

Porton Will Be Participating In Biotech Outsourcing Strategies Events This June

At this year's conference, Porton will showcase its end-to-end global CDMO service capabilities and the differentiated advantages it offers to customers. Whether its new drug development, process transfer optimization, or commercial manufacturing, Porton is committed to actively listening to customer needs and providing efficient, precise CDMO solutions.

On May 22, 2024, Porton PharmaTech celebrated the grand opening of its state-of-the-art research and development laboratories for active pharmaceutical ingredients (APIs) and small molecules in Mengeš. This event marks another significant milestone in Porton's globalization journey, following the acquisition of the US-based CRO, J-STAR Research Inc., in 2017. Globalization remains our top strategic priority at Porton, as we strive to establish R&D and manufacturing footprints in the United States and Europe. This expansion is designed to meet the growing demands of our global clients for enhanced supply chain security, high-quality, innovative, and reliable services.

Furthermore, this BOS Basel will continue the tradition of previous events by featuring four core activities: Partnering; Exhibition, Informal Networking and more. Porton will actively participate in these segments, sharing experiences, building connections, and fostering collaborations with global peers. We look forward to gathering with industry colleagues in the beautiful city of Basel to witness the brilliant future of the biotech outsourcing field together!

Porton Will Be Participating In Biotech Outsourcing Strategies Events This June

For business meeting appointments,

please contact: business@portonpharma.com.

SHARE

Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Porton Will Be Participating In Biotech Outsourcing Strategies Events This June
Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details